Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and pharmacologic phase I study of Cemadotin-HCl (LU103793), a novel antimitotic peptide, given as 24-hour infusion in patients with advanced cancer. A study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) Phase I Group and Arbeitsgruppe Pharmakologie in der Onkologie und Haematologie (APOH) Group of the German Cancer Society.
Mross K, Berdel WE, Fiebig HH, Velagapudi R, von Broen IM, Unger C. Mross K, et al. Ann Oncol. 1998 Dec;9(12):1323-30. doi: 10.1023/a:1008430515881. Ann Oncol. 1998. PMID: 9932163 Free article. Clinical Trial.
Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study.
Schultheis B, Folprecht G, Kuhlmann J, Ehrenberg R, Hacker UT, Köhne CH, Kornacker M, Boix O, Lettieri J, Krauss J, Fischer R, Hamann S, Strumberg D, Mross KB. Schultheis B, et al. Among authors: mross kb. Ann Oncol. 2013 Jun;24(6):1560-7. doi: 10.1093/annonc/mdt056. Epub 2013 Mar 13. Ann Oncol. 2013. PMID: 23493136 Free PMC article. Clinical Trial.
Clinical phase I study with one-hour paclitaxel infusion.
Mross K, Hauns B, Häring B, Bauknecht T, Meerpohl HG, Unger C, Maier-Lenz H. Mross K, et al. Ann Oncol. 1998 May;9(5):569-72. doi: 10.1023/a:1008217429971. Ann Oncol. 1998. PMID: 9653500 Free article. Clinical Trial.
A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors.
Mross K, Richly H, Schleucher N, Korfee S, Tewes M, Scheulen ME, Seeber S, Beinert T, Schweigert M, Sauer U, Unger C, Behringer D, Brendel E, Haase CG, Voliotis D, Strumberg D. Mross K, et al. Ann Oncol. 2004 Aug;15(8):1284-94. doi: 10.1093/annonc/mdh313. Ann Oncol. 2004. PMID: 15277271 Free article. Clinical Trial.
Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors.
Drevs J, Siegert P, Medinger M, Mross K, Strecker R, Zirrgiebel U, Harder J, Blum H, Robertson J, Jürgensmeier JM, Puchalski TA, Young H, Saunders O, Unger C. Drevs J, et al. Among authors: mross k. J Clin Oncol. 2007 Jul 20;25(21):3045-54. doi: 10.1200/JCO.2006.07.2066. J Clin Oncol. 2007. PMID: 17634482 Clinical Trial.
136 results